The Georgetown Lombardi Comprehensive Cancer Center, located in Washington, D.C., is one of the oldest and most respected cancer centers in the United States. As a National Cancer Institute (NCI)-designated comprehensive cancer center, Georgetown Lombardi is at the forefront of cancer research, treatment, and education. The center's team of experts, including renowned physicians, researchers, and scientists, work together to provide patients with the most advanced and personalized cancer care available.
Expertise in Cancer Research and Treatment
Georgetown Lombardi’s experts are leaders in their fields, with a deep understanding of the complex biology of cancer and the latest advancements in cancer treatment. The center’s research programs focus on a range of cancer types, including breast, lung, colon, and hematologic cancers, as well as cancer prevention and control. With a strong commitment to translational research, Georgetown Lombardi’s experts work to rapidly move discoveries from the laboratory to the clinic, where they can benefit patients.
Cancer Genetics and Genomics
Georgetown Lombardi’s experts in cancer genetics and genomics are working to understand the genetic basis of cancer and to develop new treatments that target specific genetic mutations. Using advanced technologies such as next-generation sequencing, the center’s researchers are able to analyze the genetic profiles of tumors and identify potential therapeutic targets. This expertise has led to the development of new treatments, including targeted therapies and immunotherapies, which are showing great promise in the clinic.
| Cancer Type | Genetic Mutation | Treatment Option |
|---|---|---|
| Breast Cancer | BRCA1/2 | PARP inhibitors |
| Lung Cancer | EGFR | Tyrosine kinase inhibitors |
| Colon Cancer | KRAS | Targeted therapies |
Clinical Trials and Patient Care
Georgetown Lombardi’s experts are committed to providing patients with access to the latest and most innovative cancer treatments through clinical trials. The center’s clinical trials program offers a range of studies, including phase I, II, and III trials, as well as observational studies and registry trials. With a strong focus on patient-centered care, Georgetown Lombardi’s experts work to ensure that patients receive the highest quality care, from diagnosis through treatment and follow-up.
Personalized Medicine
Georgetown Lombardi’s experts are leaders in the field of personalized medicine, which involves tailoring treatment to the individual patient’s unique genetic profile and medical history. Using advanced technologies such as genomic analysis and biomarker testing, the center’s researchers are able to identify the most effective treatments for each patient and to monitor their response to therapy. This approach has shown great promise in improving patient outcomes and reducing the risk of adverse effects.
Key Points
- Georgetown Lombardi Comprehensive Cancer Center is a NCI-designated comprehensive cancer center
- The center's experts are leaders in cancer research, treatment, and education
- Georgetown Lombardi's research programs focus on a range of cancer types, including breast, lung, colon, and hematologic cancers
- The center's clinical trials program offers a range of studies, including phase I, II, and III trials
- Georgetown Lombardi's experts are committed to providing patients with personalized, patient-centered care
As a leading cancer center, Georgetown Lombardi Comprehensive Cancer Center is dedicated to providing patients with the most advanced and effective cancer treatments available. With a strong focus on research, education, and patient care, the center's experts are working to improve patient outcomes and to reduce the burden of cancer on individuals and families.
What types of cancer are treated at Georgetown Lombardi Comprehensive Cancer Center?
+Georgetown Lombardi Comprehensive Cancer Center treats a range of cancer types, including breast, lung, colon, and hematologic cancers, as well as other types of cancer.
What is the center's approach to personalized medicine?
+Georgetown Lombardi's experts use advanced technologies such as genomic analysis and biomarker testing to tailor treatment to the individual patient's unique genetic profile and medical history.
What types of clinical trials are available at Georgetown Lombardi Comprehensive Cancer Center?
+The center's clinical trials program offers a range of studies, including phase I, II, and III trials, as well as observational studies and registry trials.
Meta description suggestion: “Georgetown Lombardi Comprehensive Cancer Center experts provide personalized cancer care and treatment options, including clinical trials and innovative therapies.” (149 characters)
